Reportlinker Adds Epidemiology: Hepatitis B in China

NEW YORK, March 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Epidemiology: Hepatitis B in China

http://www.reportlinker.com/p0460811/Epidemiology-Hepatitis-B-in-China.html

Even with the projected overall decrease during the forecast period, the prevalence of hepatitis B will continue to remain at the intermediate endemicity level. China will have an estimated 63.06 million prevalent cases of hepatitis B in 2020. Gain insight into market potential, including a robust, 10-year epidemiology forecast of hepatitis B prevalent cases. Understand the key epidemiologic risk factors associated with hepatitis B in China. Datamonitor estimates that the prevalence of hepatitis B in China is highest among adults aged 40–49 years and also 50–59 years; both age groups are projected to have an increase in the number of prevalent cases during the forecast period, according to Datamonitor forecasts. The increase in the two oldest groups (40–49 and 50–59) is directly related to the projected population growth in these age groups. The two age groups will remain unaffected by the change in vaccination policy during the forecast period. What are the most robust sources for hepatitis B prevalence data? How will patient the population change over the next decade in China? How do changes in population structure and risk factors affect the trend in prevalent hepatitis B cases?

Executive Summary

OVERVIEW

Catalyst

Summary

DISEASE DEFINITION AND DIAGNOSIS CRITERIA

Modes of transmission

Vaccinations

Diagnosis Criteria

TEMPORAL TRENDS

Changing vaccination policy

Changing disease prevalence

Changing transmission patterns

RISK FACTORS

Unsafe medical practices

Blood transfusions

Unsafe injection practices

Rural and urban residential setting

CO-MORBIDITIES

Concurrent Human Immunodeficiency Virus infection

EPIDEMIOLOGIC FORECASTING

Sources of epidemiologic data

Description of methods

EPIDEMIOLOGIC RESULTS

Current prevalent cases and future trends

By age group

By urban/rural setting

Average annual growth rate of disease population

DISCUSSION

Strengths of our epidemiologic projections

BIBLIOGRAPHY

Journal articles

Websites

Datamonitor Reports

APPENDIX

Module methodology

To order this report:

Epidemiology: Hepatitis B in China

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

CONTACT:  
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: +1-805-652-2626
Intl: +1-805-652-2626

SOURCE Reportlinker